Squamous cell carcinoma of the skin (excluding lip and oral mucosa) - 06/10/17
Doi : 10.1016/0190-9622(92)70074-P
Timothy M. Johnson, MD a, ⁎, Dan E. Rowe, MD b, Bruce R. Nelson, MD a, Neil A. Swanson, MD c
a From the Department of Dermatology, Otorbinolaryngology, and Surgery (Division of Plastic Surgery), University of Michigan Medical Center, Ann Arbor, Michigan
b Department of Dermatology, University of California, Los Angeles, California
c Department of Dermatology, Otorhinolaryngology, and Surgery (Division of Plastic Surgery), University of Oregon at Portland, Portland, Oregon
*Reprint requests: Timothy M. Johnson, MD, University of Michigan Medical Center, Department of Dermatology, 1910-0314 Taubman Center, Ann Arbor, MI 48109.
Résumé |
The striking impression obtained from reviewing the cancer literature is how difficult it is to analyze the data for answers to many important biologic, behavioral, prognostic, and therapeutic questions about squamous cell carcinoma of the skin. This article addresses current concepts, controversies, and management of cutaneous squamous cell carcinoma (excluding the lip and oral mucosa).
Le texte complet de cet article est disponible en PDF.| Supported in part by the Babcock Endowment Fund. |
© 1992
Publié par Elsevier Masson SAS.
Vol 26 - N° 3
P. 467-484 - mars 1992 Retour au numéro
Article précédent
- Malignant melanomas with histologic diameters less than 6 mm
- Reuven Bergman, Ilan Katz, Chaim Lichtig, Yehudith Ben-Arieh, Aharon R. Moscona, Rachel Friedman-Birnbaum
- Guidelines of care for atopic dermatitis
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?